Designing better influenza vaccines

We are using modeling and analysis approaches to determine how to optimize vaccine formulation, with a focus on the impact of dose for future universal influenza vaccines. The work is part of the Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP), which is a component of NIH’s Collaborative Influenza Vaccine Innovation Centers (CIVICs) program.